SV2A PET has shown great promise as a biomarker for the non-invasive detection of synaptic density, which can serve as a useful tool for studying synaptopathies in neurodegenerative and psychiatric disorders including AD (Cai et al., 2019; Heurling et al., 2019). The gene discussed is SV2A; the disease is Alzheimer disease.